Gossamer Bio (GOSS) Dir. Gregory Ciongoli Receives 30,000-Share Award

What Happened

• Gregory Austin Ciongoli, a director of Gossamer Bio (GOSS), was granted a derivative equity award for 30,000 shares on 2026-09-23. The award was reported as acquired at $0.00 per share (total reported value $0 in the Form 4), indicating an equity grant rather than a cash purchase or sale.

Key Details

• Transaction date: 2026-09-23; Form 4 filed: 2026-09-25 (timely filing).
• Reported price: $0.00 per share; total reported consideration: $0 (derivative award).
• Shares granted: 30,000 (derivative award subject to vesting).
• Vesting note: 1/36th of the total number of shares vests on the last day of each one‑month period thereafter, subject to continuous service (i.e., monthly vesting over 36 months).
• Shares owned after the transaction: not specified in the provided excerpt of the filing.

Context

• This is an equity award (derivative) rather than an open‑market purchase or sale. Such awards typically represent future potential ownership as the grant vests over time and do not indicate an immediate change in market exposure.
• For retail investors, awards to directors are common as compensation alignment and are not direct bullish/bearish signals by themselves; monitor vesting schedules and any subsequent exercises or sales reported on future Form 4s.